Tzu-Hao Chen , Chien-Chin Hsu , Hung-Jung Lin , Chung-Han Ho , Ching-Ping Chang , Chien-Cheng Huang , Ying-Jan Wang
{"title":"Carbon monoxide poisoning triggers intestinal injury, inflammation, and microbiota dysbiosis that drive metabolic perturbations","authors":"Tzu-Hao Chen , Chien-Chin Hsu , Hung-Jung Lin , Chung-Han Ho , Ching-Ping Chang , Chien-Cheng Huang , Ying-Jan Wang","doi":"10.1016/j.lfs.2025.123839","DOIUrl":null,"url":null,"abstract":"<div><h3>Aims</h3><div>To determine whether carbon monoxide poisoning (COP) increases the long-term risk of intestinal diseases and to elucidate the underlying mechanisms through translational investigation using both population data and animal experiments.</div></div><div><h3>Materials and methods</h3><div>An epidemiological study using the Taiwan National Health Insurance Research Database identified 11,025 COP patients and matched controls to assess long-term intestinal disease risk. A rat COP model was used to evaluate intestinal injury, permeability, and tight junction integrity. Systemic inflammation and immune cell populations were assessed. Gastrointestinal and stress/metabolic hormones and metabolic markers were measured. Gut microbiota was analyzed by 16S rRNA sequencing, with functional prediction using Tax4Fun and KEGG.</div></div><div><h3>Key findings</h3><div>COP increased long-term intestinal disease risk in humans. Rats showed duodenal and jejunal injury with elevated permeability and barrier disruption. Systemic inflammation (increased CX3CL1, CXCL7, IL1-α/β, CXCL5, CCL20, TIMP-1, CD54) and immune activation (increased CD86<sup>+</sup> macrophages, neutrophils, CD4<sup>+</sup> T cells) were observed. Hormones (decreased cholecystokinin and insulin; increased glucagon-like peptide-1, ghrelin, glucose-dependent insulinotropic polypeptide, cortisol) and metabolism were altered (increased glucose and lipids). Microbiota alterations, including increased <em>Mycoplasma</em>, <em>Streptococcus</em>, and <em>Desulfovibrio</em>, were associated not only with proinflammatory cytokine responses but also with metabolic dysregulation, including lipid imbalance and pathways linked to type II diabetes mellitus.</div></div><div><h3>Significance</h3><div>This study provides the first integrated clinical and experimental evidence linking COP to intestinal and metabolic dysfunction. A pathogenic axis involving gut barrier disruption, microbiota dysbiosis, and metabolic-immune imbalance may underlie COP-related chronic diseases. These findings suggest targets for early monitoring and intervention.</div></div>","PeriodicalId":18122,"journal":{"name":"Life sciences","volume":"378 ","pages":"Article 123839"},"PeriodicalIF":5.2000,"publicationDate":"2025-07-06","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Life sciences","FirstCategoryId":"3","ListUrlMain":"https://www.sciencedirect.com/science/article/pii/S0024320525004746","RegionNum":2,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q1","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0
Abstract
Aims
To determine whether carbon monoxide poisoning (COP) increases the long-term risk of intestinal diseases and to elucidate the underlying mechanisms through translational investigation using both population data and animal experiments.
Materials and methods
An epidemiological study using the Taiwan National Health Insurance Research Database identified 11,025 COP patients and matched controls to assess long-term intestinal disease risk. A rat COP model was used to evaluate intestinal injury, permeability, and tight junction integrity. Systemic inflammation and immune cell populations were assessed. Gastrointestinal and stress/metabolic hormones and metabolic markers were measured. Gut microbiota was analyzed by 16S rRNA sequencing, with functional prediction using Tax4Fun and KEGG.
Key findings
COP increased long-term intestinal disease risk in humans. Rats showed duodenal and jejunal injury with elevated permeability and barrier disruption. Systemic inflammation (increased CX3CL1, CXCL7, IL1-α/β, CXCL5, CCL20, TIMP-1, CD54) and immune activation (increased CD86+ macrophages, neutrophils, CD4+ T cells) were observed. Hormones (decreased cholecystokinin and insulin; increased glucagon-like peptide-1, ghrelin, glucose-dependent insulinotropic polypeptide, cortisol) and metabolism were altered (increased glucose and lipids). Microbiota alterations, including increased Mycoplasma, Streptococcus, and Desulfovibrio, were associated not only with proinflammatory cytokine responses but also with metabolic dysregulation, including lipid imbalance and pathways linked to type II diabetes mellitus.
Significance
This study provides the first integrated clinical and experimental evidence linking COP to intestinal and metabolic dysfunction. A pathogenic axis involving gut barrier disruption, microbiota dysbiosis, and metabolic-immune imbalance may underlie COP-related chronic diseases. These findings suggest targets for early monitoring and intervention.
期刊介绍:
Life Sciences is an international journal publishing articles that emphasize the molecular, cellular, and functional basis of therapy. The journal emphasizes the understanding of mechanism that is relevant to all aspects of human disease and translation to patients. All articles are rigorously reviewed.
The Journal favors publication of full-length papers where modern scientific technologies are used to explain molecular, cellular and physiological mechanisms. Articles that merely report observations are rarely accepted. Recommendations from the Declaration of Helsinki or NIH guidelines for care and use of laboratory animals must be adhered to. Articles should be written at a level accessible to readers who are non-specialists in the topic of the article themselves, but who are interested in the research. The Journal welcomes reviews on topics of wide interest to investigators in the life sciences. We particularly encourage submission of brief, focused reviews containing high-quality artwork and require the use of mechanistic summary diagrams.